Find policies, billing codes, payers, states, and providers
Loading...
Find policies, billing codes, payers, states, and providers
CPT 21920: Superficial Soft Tissue Biopsy of Back or Flank
CPT-21925-DEEP-SOFT-TISSUE-BIOPSY-BACK-FLANKCPT 21925: Deep Soft Tissue Biopsy of Back or Flank
CPT-21930-SOFT-TISSUE-MASS-EXCISION-BACK-FLANK-LESS-THAN-3CMCPT 21930: Excision of Subcutaneous Soft-Tissue Lesion, Back/Flank (<3 cm)
CPT-21931-SOFT-TISSUE-EXCISION-BACK-FLANK-3CM-OR-GREATERCPT 21931: Excision of Soft Tissue Mass of Back/Flank ≥3 cm
CPT-21932-SUBFASCIAL-SOFT-TISSUE-TUMOR-EXCISION-BACK-FLANKCPT 21932: Subfascial Soft Tissue Tumor Excision, Back/Flank (<5 cm)
CPT-21933-SUBFASCIAL-SOFT-TISSUE-TUMOR-EXCISION-BACK-FLANK-5CM-PLUSCPT 21933: Subfascial Soft Tissue Tumor Excision, Back or Flank (≥5 cm)
CPT-21935-EXTENSIVE-EXCISION-SOFT-TISSUE-TUMOR-BACK-FLANK-LESS-5CMCPT 21935: Extensive Excision of Malignant Soft Tissue Tumor, Back/Flank <5cm
CPT-21936-EXTENSIVE-EXCISION-SOFT-TISSUE-SARCOMA-BACK-FLANK-5CMCPT 21936: Extensive Excision of Large Soft Tissue Malignant Tumor
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.